Literature DB >> 14715691

Spontaneous fusion of cells between species yields transdifferentiation and retroviral transfer in vivo.

Brenda M Ogle1, Kim A Butters, Timothy B Plummer, Kevin R Ring, Bruce E Knudsen, Mark R Litzow, Marilia Cascalho, Jeffrey L Platt.   

Abstract

Human cells can fuse with damaged or diseased somatic cells in vivo. Whether human cells fuse in vivo in the absence of disease and with cells of disparate species is unknown. Such a question is of current interest because blood exchanges between species through direct physical contact, via insect vectors or parasitism, are thought to underlie the transmission of zoonotic agents. In a model of human-pig chimerism, we show that some human hematopoietic stem cells engrafted in pigs contain both human and porcine chromosomal DNA. These hybrid cells divide, express human and porcine proteins, and contribute to porcine nonhematopoietic tissues. In addition, the hybrid cells contain porcine endogenous retroviral DNA sequences and are able to transmit this virus to uninfected human cells in vitro. Thus, spontaneous fusion can occur in vivo between the cells of disparate species and in the absence of disease. The ability of these cell hybrids to acquire and transmit retroviral elements together with their ability to integrate into tissues could explain genetic recombination and generation of novel pathogens. * differentiation * fusion * retrovirus

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715691     DOI: 10.1096/fj.03-0962fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  21 in total

1.  A Cre-Lox P recombination approach for the detection of cell fusion in vivo.

Authors:  Anthony J Sprangers; Brian T Freeman; Nicholas A Kouris; Brenda M Ogle
Journal:  J Vis Exp       Date:  2012-01-04       Impact factor: 1.355

2.  Reliable classification and recombination analysis of porcine endogenous retroviruses.

Authors:  Nikolai Klymiuk; Bernhard Aigner
Journal:  Virus Genes       Date:  2005-05       Impact factor: 2.332

3.  The future of organ replacement: needs, potential applications, and obstacles to application.

Authors:  M Cascalho; J L Platt
Journal:  Transplant Proc       Date:  2006-03       Impact factor: 1.066

4.  A nondenatured, noncrosslinked collagen matrix to deliver stem cells to the heart.

Authors:  Nicholas A Kouris; Jayne M Squirrell; Jangwook P Jung; Carolyn A Pehlke; Timothy Hacker; Kevin W Eliceiri; Brenda M Ogle
Journal:  Regen Med       Date:  2011-09       Impact factor: 3.806

5.  Tracking fusion of human mesenchymal stem cells after transplantation to the heart.

Authors:  Brian T Freeman; Nicholas A Kouris; Brenda M Ogle
Journal:  Stem Cells Transl Med       Date:  2015-04-06       Impact factor: 6.940

6.  Cell Fusion Connects Oncogenesis with Tumor Evolution.

Authors:  Xiaofeng Zhou; Kevin Merchak; Woojin Lee; Joseph P Grande; Marilia Cascalho; Jeffrey L Platt
Journal:  Am J Pathol       Date:  2015-06-08       Impact factor: 4.307

7.  Current status of animal-to-human transplantation.

Authors:  Robert Zhong; Jeffrey L Platt
Journal:  Expert Opin Biol Ther       Date:  2005-11       Impact factor: 4.388

8.  Human pontine glioma cells can induce murine tumors.

Authors:  Viola Caretti; A Charlotte P Sewing; Tonny Lagerweij; Pepijn Schellen; Marianna Bugiani; Marc H A Jansen; Dannis G van Vuurden; Anna C Navis; Ilona Horsman; W Peter Vandertop; David P Noske; Pieter Wesseling; Gertjan J L Kaspers; Javad Nazarian; Hannes Vogel; Esther Hulleman; Michelle Monje; Thomas Wurdinger
Journal:  Acta Neuropathol       Date:  2014-04-29       Impact factor: 17.088

9.  Toward development and production of human T cells in swine for potential use in adoptive T cell immunotherapy.

Authors:  Brenda M Ogle; Bruce E Knudsen; Ryuta Nishitai; Kiyoshi Ogata; Jeffrey L Platt
Journal:  Tissue Eng Part A       Date:  2009-05       Impact factor: 3.845

Review 10.  New and old technologies for organ replacement.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Curr Opin Organ Transplant       Date:  2013-04       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.